AI Tool Analyzes CT Scans to Accurately Predict Which COVID-19 Patients Will Need Ventilator to Breathe
An online artificial intelligence (AI) tool to help medical staff can quickly determine from initial chest scans which COVID-19 patients will need help breathing with a ventilator. More...06 Sep 2021
Monoclonal Antibody Treatment Combination Reduces Hospitalization Among High-Risk COVID-19 Patients
In an observational study, researchers have reported that the combination of casirivimab and imdevimab - two monoclonal antibody treatments under Food and Drug Administration emergency use authorization – can keep high-risk patients out of the hospital when infected with mild to moderate COVID-19. More...31 Aug 2021
Unsupervised AI Predicts COVID-19 Progression and Patient Survival Directly from Chest CT Images
Unsupervised artificial intelligence (AI) has broken new ground by predicting the progression of COVID-19 and survival of patients directly from their chest computed tomography (CT) images. More...31 Aug 2021
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Plasma Freezer
iBF125-GX
New
Digital Radiographic System
OMNERA 300M
In Other News
Gilead’s Remdesivir Delivered Orally in Capsule Could Reduce COVID Hospitalizations
Low-Cost, Easy-to-Use Breathing Device to Help Cope with Surge in COVID-19 Cases in Poorer Resourced Healthcare Settings
Pfizer-BioNTech’s Comirnaty Becomes First COVID-19 Vaccine to Receive Full US FDA Approval
Moderately Ill COVID-19 Patients Treated with Therapeutic-Dose Anticoagulation Have Better Chances of Survival
Groundbreaking Study Uses AI-Powered Image Cell Analysis to Identify New COVID-19 Drug Available at Local Pharmacies
Newly-Identified Antibody Proves Highly Protective at Low Doses Against Broad Range of COVID-19 Virus Variants
Over-the-Counter Acid Suppressant Could Be Secretly Helping People Survive COVID-19
Aspirin’s Lung-Protective Effects May Decrease Ventilation, ICU Admission and Death in COVID-19 Patients
Convalescent Plasma Shows No Significant Benefit for COVID-19 Outpatients with Early Symptoms in Latest Study
New Innovative Method Tests Effectiveness of COVID-19 Drugs for Treatment of SARS-CoV-2 Infection
FDA Authorizes Third Dose of Pfizer-BioNTech and Moderna COVID-19 Vaccines for Immunocompromised Individuals
WHO Rolls Out Unprecedented Global Trial to Study New Drugs that Could Lower Mortality in COVID-19 Patients
Siemens AI-based COVID-19 Severity Algorithm Becomes Available to Help Clinicians Predict Progression to Severe Disease
Identification of Promising Inhibitors Could Lead to New Antiviral Drugs to Treat COVID-19 Infections
Highly Advanced AI Model Precisely Detects COVID-19 by Analyzing Lung Images
Unsupervised AI Model Accurately Predicts COVID-19 Patient's Survival Based on Chest CT Exams
Regeneron’s Investigational Antibody Cocktail Granted FDA EUA for Preventing COVID-19
Highly Potent Mini-Antibodies '1000 Times' Better at Neutralizing SARS-CoV-2 Could Be Promising Agents to Treat COVID-19
Eli Lilly and Incyte’s Baricitinib Reduces Deaths among COVID-19 Patients Receiving Invasive Mechanical Ventilation
Follow-Up Research Provides Key Insights into COVID-19 Vaccine Efficacy
Eli Lilly and Incyte’s Baricitinib Receives FDA EUA for Use as Monotherapy in Hospitalized COVID-19 Patients Requiring Oxygen
Vaccinated Individuals with Lower Level of Antibodies Face Higher Risk of COVID-19 Breakthrough Infections, Finds New Research
AI COVID-19 Survival Calculator Provides Patient's Risk Score, Expected Time to Death and Survival Probability
